Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|AGS-PSCA||AGS-PSCA is a human monoclonal antibody against prostate stem cell antigen, which may result in tumor growth inhibition by specifically blocking the growth of prostate cancer cells expressing PSCA (PMID: 22553195).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||prostate cancer||not applicable||AGS-PSCA||Phase Ib/II||Actionable||In a Phase Ib/II trial, AGS-PSCA treatment was deemed safe, but only resulted in limited antitumor activity in patients with castration resistant prostate cancer (PMID: 22553195).||22553195|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|